Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $9.12 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.77.
Market Cap
9.12T
Revenue
4.59T
Profits
199.16B
PE Ratio
45.77
Profit Margin
4.34%
Dividend Yield
0.39%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.07T | -1.14% | 2,343,457 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 624.26B | -1.41% | 6,673,180 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 450.11B | -2.42% | 6,876,016 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 379.60B | -1.73% | 5,951,441 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 313.12B | -2.15% | 9,181,666 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 292.08B | -2.56% | 1,871,529 | 60.44B |
| 7 | NVS | Novartis AG | 291.47B | -2.76% | 1,908,968 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 217.08B | -2.32% | 10,322,210 | 50.57B |
| 9 | AMGN | Amgen Inc. | 197.77B | -2.06% | 2,786,328 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 192.35B | -1.12% | 1,813,480 | 45.20B |
| 11 | ABT | Abbott Laboratories | 166.57B | 0.24% | 9,734,236 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 160.92B | -1.26% | 9,806,044 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 153.29B | 1.60% | 3,409,600 | 10.58B |
| 14 | DHR | Danaher Corporation | 137.04B | -2.18% | 4,354,813 | 24.78B |
| 15 | PFE | Pfizer Inc. | 135.19B | -2.47% | 58,444,585 | 63.32B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 134.41B | 0.29% | 1,511,920 | 12.22B |
| 17 | CVS | CVS Health Corporation | 130.25B | -2.52% | 5,709,257 | 405.62B |
| 18 | SYK | Stryker Corporation | 124.49B | -0.55% | 2,030,125 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 115.79B | -2.46% | 9,019,828 | 48.48B |
| 20 | MDT | Medtronic plc | 106.32B | -0.16% | 10,557,612 | 36.36B |
| 21 | GSK | GSK plc | 105.53B | -1.06% | 3,776,819 | 43.29B |
| 22 | SNY | Sanofi | 102.11B | -1.27% | 4,860,528 | 54.60B |
| 23 | HCA | HCA Healthcare, Inc. | 92.52B | 1.60% | 1,247,594 | 76.39B |
| 24 | MCK | McKesson Corporation | 91.82B | -0.26% | 1,107,210 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 88.64B | -2.33% | 1,680,293 | 200.42B |
| 26 | CI | The Cigna Group | 74.59B | -2.01% | 1,421,958 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 66.29B | -1.20% | 17,115,232 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 66.11B | -0.68% | 712,951 | 14.92B |
| 29 | COR | Cencora, Inc. | 58.09B | 0.69% | 1,591,932 | 328.68B |
| 30 | ARGX | argenx SE | 57.73B | -2.43% | 249,097 | 4.74B |
| 31 | MDLN | Medline Inc. | 56.16B | -1.02% | 7,456,466 | 29.14B |
| 32 | CAH | Cardinal Health, Inc. | 55.63B | -0.59% | 2,403,367 | 250.74B |
| 33 | EW | Edwards Lifesciences Corporation | 54.80B | 0.86% | 3,055,196 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 53.69B | 0.72% | 2,881,258 | 28.34B |
| 35 | HUM | Humana Inc. | 47.17B | -0.98% | 1,020,298 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.57B | 1.29% | 628,343 | 4.45B |
| 37 | HLN | Haleon plc | 42.89B | -1.02% | 7,245,339 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 42.86B | -1.61% | 1,464,200 | 22.23B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.79B | 0.08% | 891,758 | 4.29B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 41.09B | 1.88% | 4,114,405 | 17.35B |
| 41 | NTRA | Natera, Inc. | 40.64B | 1.60% | 1,349,707 | 2.50B |
| 42 | RVMD | Revolution Medicines, Inc. | 40.39B | 0.40% | 2,398,035 | - |
| 43 | WAT | Waters Corporation | 37.20B | -0.11% | 731,354 | 3.77B |
| 44 | A | Agilent Technologies, Inc. | 36.89B | -0.07% | 1,999,855 | 7.23B |
| 45 | ONC | BeOne Medicines AG | 34.40B | 3.97% | 385,203 | 5.74B |
| 46 | IQV | IQVIA Holdings Inc. | 34.38B | -0.52% | 666,057 | 16.63B |
| 47 | ALC | Alcon Inc. | 33.22B | -1.91% | 2,028,865 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 32.78B | -1.46% | 3,105,660 | 2.44B |
| 49 | CNC | Centene Corporation | 32.62B | -2.67% | 3,576,095 | 178.33B |
| 50 | MRNA | Moderna, Inc. | 32.46B | 2.56% | 14,588,534 | 2.23B |
| 51 | ZTS | Zoetis Inc. | 31.62B | 0.83% | 7,184,839 | 9.53B |
| 52 | RMD | ResMed Inc. | 31.50B | 4.18% | 3,397,364 | 5.54B |
| 53 | VEEV | Veeva Systems Inc. | 31.19B | -0.38% | 2,277,920 | 3.32B |
| 54 | BIIB | Biogen Inc. | 30.78B | -3.54% | 1,211,838 | 9.94B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 29.50B | -1.11% | 4,894,959 | 20.98B |
| 56 | ILMN | Illumina, Inc. | 29.40B | 2.99% | 2,101,766 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 27.93B | 1.59% | 4,597,366 | 4.82B |
| 58 | PHG | Koninklijke Philips N.V. | 26.63B | 1.51% | 1,030,942 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 26.18B | -0.98% | 109,600 | 4.09B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.45B | 0.74% | 4,915,448 | 8.26M |
| 61 | WST | West Pharmaceutical Services, Inc. | 25.27B | -2.21% | 680,194 | 3.22B |
| 62 | INSM | Insmed Incorporated | 24.18B | -0.05% | 1,795,996 | 819.56M |
| 63 | BNTX | BioNTech SE | 23.75B | -3.71% | 638,126 | 3.23B |
| 64 | DGX | Quest Diagnostics Incorporated | 23.63B | -1.05% | 742,207 | 11.28B |
| 65 | LH | Labcorp Holdings Inc. | 23.32B | -0.90% | 481,772 | 14.14B |
| 66 | UTHR | United Therapeutics Corporation | 23.23B | -1.56% | 314,835 | 3.17B |
| 67 | INCY | Incyte Corporation | 23.10B | -1.06% | 898,408 | 5.36B |
| 68 | GH | Guardant Health, Inc. | 22.39B | 0.50% | 1,790,114 | 1.08B |
| 69 | STE | STERIS plc | 20.79B | -2.25% | 615,504 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.56B | 0.60% | 11,207,607 | 14.56B |
| 71 | THC | Tenet Healthcare Corporation | 17.76B | 1.21% | 1,158,162 | 21.46B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 17.51B | -0.09% | 704,677 | 3.10B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.37B | 2.62% | 2,410,828 | 8.41B |
| 74 | GMAB | Genmab A/S | 17.14B | -1.77% | 1,778,657 | 3.90B |
| 75 | ASND | Ascendis Pharma A/S | 16.64B | -2.40% | 539,847 | 998.25M |
| 76 | MEDP | Medpace Holdings, Inc. | 16.16B | 1.48% | 234,156 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.33B | 0.25% | 861,482 | 4.44B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.23B | 0.73% | 3,137,227 | 579.96M |
| 79 | DVA | DaVita Inc. | 15.13B | 0.34% | 672,384 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.70B | 2.22% | 3,261,980 | 13.65B |
| 81 | COO | The Cooper Companies, Inc. | 14.16B | -2.14% | 1,954,929 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.96B | -0.57% | 3,142,989 | 2.38B |
| 83 | IONS | Ionis Pharmaceuticals, Inc. | 13.75B | 1.69% | 1,489,735 | 1.06B |
| 84 | SOLV | Solventum Corporation | 13.50B | -0.42% | 1,089,783 | 8.26B |
| 85 | ALGN | Align Technology, Inc. | 13.49B | 2.10% | 827,015 | 4.10B |
| 86 | ICLR | ICON Public Limited Company | 13.08B | -1.34% | 700,690 | 8.27B |
| 87 | SNN | Smith & Nephew plc | 12.85B | 0.99% | 1,298,527 | 6.16B |
| 88 | ABVX | ABIVAX Société Anonyme | 12.69B | -0.46% | 1,415,738 | 5.67M |
| 89 | FMS | Fresenius Medical Care AG | 12.63B | 0.34% | 529,043 | 22.32B |
| 90 | RVTY | Revvity, Inc. | 12.60B | -0.71% | 985,764 | 2.90B |
| 91 | ELAN | Elanco Animal Health Incorporated | 12.55B | 0.52% | 3,324,138 | 4.89B |
| 92 | PEN | Penumbra, Inc. | 12.52B | -0.11% | 353,532 | 1.45B |
| 93 | AXSM | Axsome Therapeutics, Inc. | 12.48B | -0.70% | 608,450 | 708.24M |
| 94 | SMMT | Summit Therapeutics Inc. | 12.36B | 3.31% | 3,915,059 | - |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.19B | 0.15% | 230,980 | 1.13B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.19B | 3.05% | 2,441,288 | 622.01M |
| 97 | RDY | Dr. Reddy's Laboratories Limited | 11.95B | -0.14% | 1,050,124 | 3.58B |
| 98 | MOH | Molina Healthcare, Inc. | 11.86B | -0.94% | 510,178 | 43.10B |
| 99 | BAX | Baxter International Inc. | 11.66B | -0.31% | 4,826,194 | 11.32B |
| 100 | CYTK | Cytokinetics, Incorporated | 11.62B | -1.06% | 1,297,670 | 105.82M |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 11.36B | -0.34% | 1,789,110 | 3.24B |
| 102 | CRL | Charles River Laboratories International, Inc. | 11.15B | 0.32% | 487,317 | 4.03B |
| 103 | PODD | Insulet Corporation | 11.07B | -2.86% | 1,365,635 | 2.90B |
| 104 | TECH | Bio-Techne Corporation | 11.05B | 0.13% | 6,142,609 | 1.21B |
| 105 | KRYS | Krystal Biotech, Inc. | 11.03B | -0.21% | 191,322 | 417.30M |
| 106 | GMED | Globus Medical, Inc. | 10.93B | 0.47% | 1,141,121 | 3.10B |
| 107 | TEM | Tempus AI, Inc. | 10.90B | 0.71% | 4,494,859 | 1.36B |
| 108 | EHC | Encompass Health Corporation | 10.61B | 0.50% | 1,048,933 | 6.07B |
| 109 | APGE | Apogee Therapeutics, Inc. | 10.00B | 0.43% | 1,560,525 | - |
| 110 | HSIC | Henry Schein, Inc. | 9.87B | 0.22% | 956,130 | 13.38B |
| 111 | CORT | Corcept Therapeutics Incorporated | 9.83B | 1.55% | 812,180 | 769.10M |
| 112 | NUVL | Nuvalent, Inc. | 9.77B | -0.01% | 985,649 | - |
| 113 | ENSG | The Ensign Group, Inc. | 9.67B | -0.83% | 447,474 | 5.27B |
| 114 | HALO | Halozyme Therapeutics, Inc. | 9.58B | 1.67% | 1,954,917 | 1.51B |
| 115 | UHS | Universal Health Services, Inc. | 9.57B | -0.18% | 578,853 | 17.76B |
| 116 | OSCR | Oscar Health, Inc. | 9.47B | -2.30% | 5,181,628 | 13.30B |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.47B | 1.37% | 625,138 | 51.48M |
| 118 | BRKR | Bruker Corporation | 9.34B | -0.49% | 2,441,811 | 3.46B |
| 119 | IBRX | ImmunityBio, Inc. | 9.33B | -5.61% | 13,444,189 | 140.98M |
| 120 | ALKS | Alkermes plc | 9.19B | 1.03% | 1,743,614 | 1.56B |
| 121 | HIMS | Hims & Hers Health, Inc. | 8.86B | 4.02% | 13,753,526 | 2.37B |
| 122 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | -1.58% | 387,253 | 7.46M |
| 123 | GKOS | Glaukos Corporation | 8.73B | 0.24% | 712,919 | 551.35M |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.45B | -0.12% | 639,781 | 74.06M |
| 125 | PCVX | Vaxcyte, Inc. | 8.22B | -2.45% | 1,310,612 | - |
| 126 | QGEN | Qiagen N.V. | 8.10B | -2.37% | 2,215,749 | 2.10B |
| 127 | HQY | HealthEquity, Inc. | 8.07B | 1.32% | 714,287 | 1.34B |
| 128 | ATR | AptarGroup, Inc. | 8.04B | -0.76% | 431,430 | 3.87B |
| 129 | RGEN | Repligen Corporation | 7.98B | -0.66% | 666,682 | 763.34M |
| 130 | IMVT | Immunovant, Inc. | 7.92B | -0.49% | 1,066,372 | - |
| 131 | BIO | Bio-Rad Laboratories, Inc. | 7.90B | -0.58% | 157,203 | 2.59B |
| 132 | TGTX | TG Therapeutics, Inc. | 7.85B | 3.96% | 2,699,490 | 700.35M |
| 133 | SYRE | Spyre Therapeutics, Inc. | 7.71B | 2.44% | 1,369,182 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.65B | -2.18% | 672,630 | 217.17M |
| 135 | MIRM | Mirum Pharmaceuticals, Inc. | 7.43B | -2.92% | 449,254 | 569.61M |
| 136 | PACS | PACS Group, Inc. | 7.12B | 1.17% | 1,312,694 | 5.43B |
| 137 | PTCT | PTC Therapeutics, Inc. | 7.09B | 2.56% | 3,805,583 | 827.11M |
| 138 | AVTR | Avantor, Inc. | 7.08B | 0.48% | 7,511,589 | 6.55B |
| 139 | LQDA | Liquidia Corporation | 7.04B | 0.35% | 1,714,218 | 288.07M |
| 140 | HNGE | Hinge Health, Inc. | 6.85B | 5.32% | 1,691,890 | 646.34M |
| 141 | COGT | Cogent Biosciences, Inc. | 6.74B | 1.94% | 1,465,321 | - |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.69B | -6.43% | 1,022,664 | 1.55B |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.63B | 0.87% | 962,614 | - |
| 144 | CHE | Chemed Corporation | 6.35B | -1.87% | 135,618 | 2.54B |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.35B | 0.22% | 340,636 | 274.48M |
| 146 | GRFS | Grifols, S.A. | 6.24B | 0.14% | 1,221,708 | 8.58B |
| 147 | TWST | Twist Bioscience Corporation | 6.22B | 0.70% | 1,446,306 | 409.48M |
| 148 | CGON | CG Oncology, Inc. | 6.11B | -1.56% | 526,081 | 5.07M |
| 149 | BLCO | Bausch + Lomb Corporation | 6.10B | -0.29% | 299,584 | 5.21B |
| 150 | BLTE | Belite Bio, Inc | 6.06B | 5.04% | 205,780 | - |
| 151 | CRSP | CRISPR Therapeutics AG | 5.97B | 3.01% | 1,690,377 | 4.10M |
| 152 | TFX | Teleflex Incorporated | 5.95B | 0.25% | 435,018 | 2.13B |
| 153 | DFTX | Definium Therapeutics, Inc. | 5.88B | 0.32% | 2,073,597 | - |
| 154 | ERAS | Erasca, Inc. | 5.86B | 2.06% | 4,537,320 | - |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 5.85B | -0.69% | 1,734,646 | 7.50M |
| 156 | BLLN | BillionToOne, Inc. | 5.68B | 2.53% | 780,054 | 354.54M |
| 157 | LEGN | Legend Biotech Corporation | 5.42B | -6.25% | 1,523,905 | 1.14B |
| 158 | RDNT | RadNet, Inc. | 5.42B | 0.25% | 1,105,221 | 2.14B |
| 159 | AMRX | Amneal Pharmaceuticals, Inc. | 5.40B | -1.34% | 1,247,152 | 3.05B |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.35B | 0.98% | 1,520,568 | 536.20M |
| 161 | CELC | Celcuity Inc. | 5.30B | 0.58% | 875,334 | - |
| 162 | STVN | Stevanato Group S.p.A. | 5.26B | 1.47% | 234,690 | 1.39B |
| 163 | DNTH | Dianthus Therapeutics, Inc. | 5.10B | -1.04% | 857,531 | 1.34M |
| 164 | MANE | Veradermics, Incorporated | 5.10B | -5.91% | 536,989 | - |
| 165 | SHC | Sotera Health Company | 5.09B | -0.39% | 1,309,926 | 1.19B |
| 166 | TXG | 10x Genomics, Inc. | 5.08B | 2.54% | 2,329,240 | 638.78M |
| 167 | ALHC | Alignment Healthcare, Inc. | 5.08B | 3.19% | 3,454,198 | 4.26B |
| 168 | CAI | Caris Life Sciences, Inc. | 5.03B | -2.68% | 1,889,164 | 907.29M |
| 169 | ORKA | Oruka Therapeutics, Inc. | 5.01B | -2.44% | 1,579,405 | - |
| 170 | INDV | Indivior Pharmaceuticals, Inc. | 4.88B | 0.48% | 1,944,962 | 1.29B |
| 171 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.83B | -2.73% | 629,827 | 754.05M |
| 172 | VCYT | Veracyte, Inc. | 4.63B | 1.60% | 704,639 | 541.74M |
| 173 | LIVN | LivaNova PLC | 4.62B | 0.49% | 548,811 | 1.43B |
| 174 | WAY | Waystar Holding Corp. | 4.59B | 1.92% | 2,405,607 | 1.16B |
| 175 | VKTX | Viking Therapeutics, Inc. | 4.49B | 3.39% | 1,796,418 | - |
| 176 | NVST | Envista Holdings Corporation | 4.48B | -0.43% | 2,146,191 | 2.81B |
| 177 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.43B | -0.47% | 5,027,103 | 18.07M |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 4.41B | -0.77% | 1,154,807 | 1.10B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.33B | 1.63% | 1,790,546 | 56.99M |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.31B | 1.26% | 418,987 | - |
| 181 | MMED | MiniMed Group, Inc. | 4.29B | -1.92% | 1,031,201 | 3.10B |
| 182 | MMSI | Merit Medical Systems, Inc. | 4.26B | 0.51% | 645,872 | 1.54B |
| 183 | LFST | LifeStance Health Group, Inc. | 4.26B | -2.48% | 4,406,643 | 1.49B |
| 184 | DOCS | Doximity, Inc. | 4.18B | 4.57% | 3,658,292 | 644.86M |
| 185 | IRTC | iRhythm Holdings, Inc. | 4.14B | -0.36% | 678,429 | 787.85M |
| 186 | RLAY | Relay Therapeutics, Inc. | 4.12B | 1.34% | 3,109,551 | 10.68M |
| 187 | TLX | Telix Pharmaceuticals Limited | 4.09B | 2.36% | 200,495 | 803.79M |
| 188 | DNLI | Denali Therapeutics Inc. | 4.09B | -0.23% | 1,326,937 | - |
| 189 | NAMS | NewAmsterdam Pharma Company N.V. | 4.08B | 0.20% | 801,632 | 22.57M |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 4.07B | -0.22% | 1,036,412 | 2.23B |
| 191 | ICUI | ICU Medical, Inc. | 3.99B | 2.93% | 347,976 | 2.16B |
| 192 | GPCR | Structure Therapeutics Inc. | 3.89B | 2.43% | 460,232 | - |
| 193 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.86B | 0.16% | 700,938 | 596.96M |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.78B | -0.91% | 2,919,526 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.77B | -1.15% | 761,867 | 236.00M |
| 196 | IDYA | IDEAYA Biosciences, Inc. | 3.75B | 4.73% | 1,610,427 | 225.27M |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.72B | -1.28% | 273,255 | - |
| 198 | BKD | Brookdale Senior Living Inc. | 3.72B | -1.89% | 3,229,107 | 3.00B |
| 199 | WRBY | Warby Parker Inc. | 3.59B | -0.14% | 2,426,034 | 890.57M |
| 200 | OGN | Organon & Co. | 3.56B | 0.07% | 4,274,553 | 6.16B |
| 201 | BEAM | Beam Therapeutics Inc. | 3.52B | 1.52% | 2,402,876 | 164.01M |
| 202 | ELVN | Enliven Therapeutics, Inc. | 3.49B | 0.38% | 748,098 | - |
| 203 | ALMS | Alumis Inc. | 3.48B | 2.91% | 1,404,916 | 8.40M |
| 204 | ADPT | Adaptive Biotechnologies Corporation | 3.44B | 1.46% | 2,525,110 | 295.41M |
| 205 | PRVA | Privia Health Group, Inc. | 3.43B | -0.62% | 669,727 | 2.25B |
| 206 | HAE | Haemonetics Corporation | 3.41B | -0.07% | 519,631 | 1.33B |
| 207 | NHC | National HealthCare Corporation | 3.40B | -0.46% | 90,639 | 1.53B |
| 208 | OPCH | Option Care Health, Inc. | 3.35B | -2.51% | 2,282,195 | 5.67B |
| 209 | RARE | Ultragenyx Pharmaceutical Inc. | 3.31B | 0.69% | 1,283,674 | 670.00M |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | 1.01% | 1,274,700 | 415.62M |
| 211 | ITGR | Integer Holdings Corporation | 3.17B | -1.83% | 506,049 | 1.86B |
| 212 | KLRA | Kailera Therapeutics, Inc. | 3.02B | 5.96% | 482,534 | - |
| 213 | CLDX | Celldex Therapeutics, Inc. | 2.98B | -1.09% | 470,282 | 865.00K |
| 214 | GRAL | GRAIL, Inc. | 2.96B | -0.14% | 240,489 | 156.12M |
| 215 | IRON | Disc Medicine, Inc. | 2.94B | 0.98% | 988,763 | - |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 2.88B | 2.32% | 1,287,334 | 535.08M |
| 217 | VERA | Vera Therapeutics, Inc. | 2.88B | -2.60% | 2,861,159 | - |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.86B | -2.57% | 2,467,403 | 3.37B |
| 219 | QURE | uniQure N.V. | 2.84B | -1.08% | 1,109,035 | 18.09M |
| 220 | RGC | Regencell Bioscience Holdings Limited | 2.78B | -11.93% | 527,072 | - |
| 221 | MBX | MBX Biosciences, Inc. | 2.75B | 0.08% | 555,866 | - |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.74B | -1.77% | 878,465 | 776.83M |
| 223 | IMNM | Immunome, Inc. | 2.71B | 1.23% | 1,783,871 | 4.02M |
| 224 | ESTA | Establishment Labs Holdings Inc. | 2.69B | 2.59% | 724,538 | 229.58M |
| 225 | CLOV | Clover Health Investments, Corp. | 2.67B | -3.80% | 6,671,789 | 2.21B |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.62B | -1.48% | 189,488 | 1.46B |
| 227 | SLS | SELLAS Life Sciences Group, Inc. | 2.59B | -6.94% | 9,724,712 | - |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.58B | 3.35% | 4,367,081 | 885.72M |
| 229 | MLYS | Mineralys Therapeutics, Inc. | 2.57B | 5.16% | 1,717,111 | - |
| 230 | TRVI | Trevi Therapeutics, Inc. | 2.55B | 0.11% | 2,369,239 | - |
| 231 | NTLA | Intellia Therapeutics, Inc. | 2.49B | 1.59% | 3,531,062 | 66.09M |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.49B | 0.29% | 723,043 | 71.78M |
| 233 | NKTR | Nektar Therapeutics | 2.47B | 2.97% | 957,928 | 55.63M |
| 234 | XRAY | DENTSPLY SIRONA Inc. | 2.47B | 5.75% | 5,875,779 | 3.68B |
| 235 | TMDX | TransMedics Group, Inc. | 2.46B | 3.44% | 782,622 | 635.89M |
| 236 | AXGN | Axogen, Inc. | 2.44B | 0.11% | 1,627,121 | 238.11M |
| 237 | PGNY | Progyny, Inc. | 2.42B | 2.35% | 1,330,361 | 1.29B |
| 238 | BHVN | Biohaven Ltd. | 2.42B | 0.56% | 1,945,730 | - |
| 239 | ABCL | AbCellera Biologics Inc. | 2.40B | -2.96% | 6,286,585 | 79.21M |
| 240 | VCEL | Vericel Corporation | 2.38B | -0.89% | 520,929 | 292.09M |
| 241 | LMAT | LeMaitre Vascular, Inc. | 2.38B | 1.05% | 186,043 | 256.28M |
| 242 | HTFL | HeartFlow, Inc. | 2.34B | -3.06% | 1,390,939 | 191.42M |
| 243 | ASTH | Astrana Health, Inc. | 2.33B | -4.60% | 636,378 | 3.53B |
| 244 | PHVS | Pharvaris N.V. | 2.32B | -1.89% | 753,087 | - |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.31B | -1.13% | 442,713 | 1.09B |
| 246 | KOD | Kodiak Sciences Inc. | 2.31B | -3.94% | 358,459 | - |
| 247 | AGIO | Agios Pharmaceuticals, Inc. | 2.23B | -0.43% | 476,102 | 66.05M |
| 248 | SGRY | Surgery Partners, Inc. | 2.20B | -1.39% | 1,144,826 | 3.34B |
| 249 | MD | Pediatrix Medical Group, Inc. | 2.20B | 2.35% | 674,448 | 1.93B |
| 250 | GENB | Generate Biomedicines, Inc. | 2.17B | -2.81% | 1,041,309 | 30.30M |
| 251 | BFLY | Butterfly Network, Inc. | 2.15B | 7.16% | 12,263,441 | 102.92M |
| 252 | KARD | Kardigan, Inc. | 2.15B | -1.31% | 304,718 | - |
| 253 | ZLAB | Zai Lab Limited | 2.14B | -0.21% | 465,963 | 453.28M |
| 254 | HRMY | Harmony Biosciences Holdings, Inc. | 2.14B | -0.67% | 443,802 | 899.11M |
| 255 | ADMA | ADMA Biologics, Inc. | 2.12B | 2.35% | 2,620,120 | 509.86M |
| 256 | OCUL | Ocular Therapeutix, Inc. | 2.12B | 0.21% | 2,407,616 | 52.04M |
| 257 | UFPT | UFP Technologies, Inc. | 2.10B | -0.14% | 303,863 | 608.85M |
| 258 | RXRX | Recursion Pharmaceuticals, Inc. | 2.10B | 4.21% | 37,996,213 | 66.41M |
| 259 | VRDN | Viridian Therapeutics, Inc. | 2.10B | -2.11% | 1,724,370 | 70.92M |
| 260 | AVAH | Aveanna Healthcare Holdings Inc. | 2.08B | 4.73% | 2,782,862 | 2.52B |
| 261 | NEOG | Neogen Corporation | 2.07B | 1.82% | 1,239,246 | 870.56M |
| 262 | OMCL | Omnicell, Inc. | 2.06B | 5.02% | 748,400 | 1.23B |
| 263 | WGS | GeneDx Holdings Corp. | 2.05B | 2.04% | 690,232 | 442.68M |
| 264 | HCM | HUTCHMED (China) Limited | 2.04B | 1.84% | 73,798 | 548.51M |
| 265 | TSHA | Taysha Gene Therapies, Inc. | 2.04B | -2.30% | 1,709,187 | 7.47M |
| 266 | LKFT | Lakefront Biotherapeutics NV | 2.03B | -0.10% | 101,559 | 1.20B |
| 267 | SRPT | Sarepta Therapeutics, Inc. | 2.02B | -0.52% | 2,845,916 | 2.18B |
| 268 | NBTX | Nanobiotix S.A. | 2.02B | 7.42% | 332,196 | 38.27M |
| 269 | STOK | Stoke Therapeutics, Inc. | 2.02B | -0.80% | 690,366 | 32.08M |
| 270 | PLSE | Pulse Biosciences, Inc. | 2.01B | -0.33% | 199,557 | 751.00K |
| 271 | PVLA | Palvella Therapeutics, Inc. | 2.01B | -4.39% | 178,016 | - |
| 272 | NVCR | NovoCure Limited | 2.01B | 0.81% | 1,681,823 | 674.41M |
| 273 | PGEN | Precigen, Inc. | 2.00B | -0.44% | 5,155,967 | 31.60M |
| 274 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.00B | -1.64% | 1,170,979 | -665.00K |
| 275 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | -0.77% | 1,470,855 | 298.30M |
| 276 | NEO | NeoGenomics, Inc. | 1.97B | - | 3,164,953 | 745.97M |
| 277 | GLUE | Monte Rosa Therapeutics, Inc. | 1.96B | -3.97% | 996,074 | 42.95M |
| 278 | SNDX | Syndax Pharmaceuticals, Inc. | 1.96B | 1.33% | 1,571,939 | 217.17M |
| 279 | ABSI | Absci Corporation | 1.95B | -0.69% | 4,930,262 | 1.84M |
| 280 | NUVB | Nuvation Bio Inc. | 1.95B | -1.75% | 5,320,036 | 143.05M |
| 281 | SION | Sionna Therapeutics, Inc. | 1.95B | -1.98% | 236,915 | - |
| 282 | ADUS | Addus HomeCare Corporation | 1.93B | 0.63% | 188,425 | 1.45B |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.92B | -2.44% | 511,248 | 367.34M |
| 284 | BCAX | Bicara Therapeutics Inc. | 1.92B | 0.76% | 531,312 | - |
| 285 | IOVA | Iovance Biotherapeutics, Inc. | 1.87B | -2.78% | 12,740,440 | 285.61M |
| 286 | MESO | Mesoblast Limited | 1.87B | -0.35% | 105,634 | 65.38M |
| 287 | ZYME | Zymeworks Inc. | 1.85B | -3.84% | 593,271 | 81.26M |
| 288 | ANAB | AnaptysBio, Inc. | 1.85B | -1.72% | 559,582 | 232.39M |
| 289 | RAPP | Rapport Therapeutics, Inc. | 1.84B | -1.03% | 266,973 | 20.00M |
| 290 | DMRA | Damora Therapeutics, Inc. | 1.83B | -0.60% | 671,446 | - |
| 291 | TYRA | Tyra Biosciences, Inc. | 1.83B | 0.62% | 490,695 | - |
| 292 | ATAI | AtaiBeckley Inc. | 1.83B | -4.43% | 11,532,481 | 3.49M |
| 293 | URGN | UroGen Pharma Ltd. | 1.82B | -1.60% | 821,948 | 140.49M |
| 294 | ANIP | ANI Pharmaceuticals, Inc. | 1.80B | -1.14% | 362,500 | 923.71M |
| 295 | BHC | Bausch Health Companies Inc. | 1.80B | -1.84% | 2,705,436 | 10.53B |
| 296 | GHRS | GH Research PLC | 1.80B | -3.11% | 118,876 | - |
| 297 | AGL | agilon health, inc. | 1.80B | -3.07% | 294,410 | 5.82B |
| 298 | MAZE | Maze Therapeutics, Inc. | 1.79B | 3.49% | 488,087 | 20.00M |
| 299 | ALMR | Alamar Biosciences, Inc. | 1.78B | -1.08% | 270,972 | 87.16M |
| 300 | CMPS | COMPASS Pathways plc | 1.73B | -5.73% | 3,193,682 | - |
| 301 | AAPG | Ascentage Pharma Group International | 1.72B | 4.70% | 12,860 | 82.08M |
| 302 | TRLV | Trulieve Cannabis Corp. | 1.70B | -9.82% | 2,222,994 | 1.17B |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.69B | -2.11% | 407,805 | 1.85B |
| 304 | VIR | Vir Biotechnology, Inc. | 1.69B | -0.20% | 1,569,839 | 65.50M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.69B | 3.30% | 923,680 | 2.71B |
| 306 | TDOC | Teladoc Health, Inc. | 1.68B | 0.98% | 3,987,076 | 2.51B |
| 307 | HROW | Harrow, Inc. | 1.67B | 5.12% | 945,683 | 268.68M |
| 308 | ZBIO | Zenas BioPharma, Inc. | 1.67B | -2.86% | 605,318 | 10.00M |
| 309 | INNV | InnovAge Holding Corp. | 1.64B | 1.00% | 431,368 | 949.17M |
| 310 | ATRC | AtriCure, Inc. | 1.64B | 1.89% | 820,611 | 552.16M |
| 311 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | 3.22% | 514,159 | 83.72M |
| 312 | IMCR | Immunocore Holdings plc | 1.62B | -1.72% | 243,291 | 412.81M |
| 313 | INVA | Innoviva, Inc. | 1.61B | -2.20% | 660,419 | 420.69M |
| 314 | AVBP | ArriVent BioPharma, Inc. | 1.61B | -0.52% | 467,321 | - |
| 315 | MPLT | MapLight Therapeutics, Inc. | 1.59B | -5.53% | 204,984 | - |
| 316 | SVRA | Savara Inc. | 1.57B | -0.32% | 1,333,811 | - |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.56B | -0.37% | 959,367 | - |
| 318 | ARDT | Ardent Health, Inc. | 1.55B | 0.56% | 643,377 | 6.43B |
| 319 | NVAX | Novavax, Inc. | 1.54B | -4.00% | 2,919,282 | 596.34M |
| 320 | PRGO | Perrigo Company plc | 1.53B | 0.64% | 2,527,939 | 4.18B |
| 321 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.52B | -2.32% | 2,369,047 | 204.73M |
| 322 | SEPN | Septerna, Inc. | 1.51B | -1.56% | 406,634 | 72.26M |
| 323 | PSNL | Personalis, Inc. | 1.50B | 5.29% | 4,307,054 | 64.52M |
| 324 | CDNA | CareDx, Inc. | 1.50B | -0.45% | 581,192 | 412.82M |
| 325 | ENOV | Enovis Corporation | 1.49B | 15.11% | 2,148,466 | 2.28B |
| 326 | AKTS | Aktis Oncology, Inc. | 1.47B | -16.37% | 886,082 | 8.28M |
| 327 | XERS | Xeris Biopharma Holdings, Inc. | 1.45B | 1.09% | 1,882,399 | 314.85M |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.43B | 4.60% | 2,286,647 | 787.08M |
| 329 | INBX | Inhibrx Biosciences, Inc. | 1.43B | -0.45% | 415,913 | 1.30M |
| 330 | INSP | Inspire Medical Systems, Inc. | 1.42B | 5.32% | 1,165,001 | 915.25M |
| 331 | IART | Integra LifeSciences Holdings Corporation | 1.41B | 0.72% | 534,181 | 1.64B |
| 332 | COAG | Hemab Therapeutics Holdings, Inc. | 1.40B | -3.32% | 618,121 | - |
| 333 | PAHC | Phibro Animal Health Corporation | 1.39B | 2.95% | 230,947 | 1.50B |
| 334 | PNTG | The Pennant Group, Inc. | 1.39B | 3.63% | 422,550 | 1.02B |
| 335 | AMN | AMN Healthcare Services, Inc. | 1.39B | 2.94% | 1,154,494 | 3.42B |
| 336 | AHCO | AdaptHealth Corp. | 1.37B | -4.55% | 1,014,340 | 3.29B |
| 337 | IMTX | Immatics N.V. | 1.37B | 0.40% | 800,892 | 43.00M |
| 338 | STAA | STAAR Surgical Company | 1.36B | -1.58% | 756,512 | 290.38M |
| 339 | OMDA | Omada Health, Inc. | 1.36B | 2.05% | 647,647 | 283.30M |
| 340 | BLFS | BioLife Solutions, Inc. | 1.36B | -1.14% | 441,383 | 101.66M |
| 341 | NUTX | Nutex Health Inc. | 1.34B | -1.27% | 184,336 | 879.95M |
| 342 | MNKD | MannKind Corporation | 1.32B | -5.53% | 4,080,043 | 360.78M |
| 343 | ARDX | Ardelyx, Inc. | 1.32B | 1.33% | 3,608,007 | 427.68M |
| 344 | IRMD | IRADIMED CORPORATION | 1.31B | 1.55% | 110,417 | 86.28M |
| 345 | AHG | Akso Health Group | 1.31B | 0.33% | 10,097 | 14.84M |
| 346 | CAPR | Capricor Therapeutics, Inc. | 1.30B | -3.34% | 2,125,023 | 11.13M |
| 347 | MGTX | MeiraGTx Holdings plc | 1.29B | -0.22% | 656,938 | 79.76M |
| 348 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | -0.26% | 1,085,258 | - |
| 349 | SDGR | Schrödinger, Inc. | 1.27B | 0.71% | 794,713 | 254.91M |
| 350 | JBIO | Jade Biosciences, Inc. | 1.27B | -0.79% | 724,064 | - |
| 351 | QDEL | QuidelOrtho Corporation | 1.23B | -1.37% | 1,059,790 | 2.66B |
| 352 | AVLN | Avalyn Pharma Inc. | 1.23B | -7.00% | 518,393 | - |
| 353 | DRTS | Alpha Tau Medical Ltd. | 1.22B | 2.61% | 1,562,642 | - |
| 354 | LMRI | Lumexa Imaging Holdings, Inc. | 1.22B | 2.17% | 434,354 | 1.03B |
| 355 | WVE | Wave Life Sciences Ltd. | 1.22B | 0.96% | 2,995,764 | 71.80M |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.22B | 1.19% | 550,231 | 796.33M |
| 357 | EYPT | EyePoint, Inc. | 1.21B | 3.29% | 1,408,113 | 7.61M |
| 358 | PRCT | PROCEPT BioRobotics Corporation | 1.21B | 0.86% | 1,407,419 | 322.02M |
| 359 | AORT | Artivion, Inc. | 1.20B | 2.88% | 679,977 | 458.69M |
| 360 | SANA | Sana Biotechnology, Inc. | 1.19B | -1.00% | 3,143,578 | - |
| 361 | AZTA | Azenta, Inc. | 1.18B | -0.66% | 526,910 | 596.48M |
| 362 | ALVO | Alvotech | 1.17B | -4.02% | 620,571 | 562.04M |
| 363 | AVNS | Avanos Medical, Inc. | 1.17B | -0.04% | 408,605 | 715.90M |
| 364 | OPK | OPKO Health, Inc. | 1.13B | -1.32% | 1,952,956 | 581.12M |
| 365 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | -6.27% | 2,619,725 | - |
| 366 | USPH | U.S. Physical Therapy, Inc. | 1.12B | 1.42% | 324,261 | 787.69M |
| 367 | OLMA | Olema Pharmaceuticals, Inc. | 1.12B | 1.03% | 1,220,876 | - |
| 368 | CERT | Certara, Inc. | 1.11B | 2.30% | 3,189,357 | 419.75M |
| 369 | XNCR | Xencor, Inc. | 1.10B | -0.67% | 404,273 | 97.36M |
| 370 | BIOA | BioAge Labs, Inc. | 1.10B | -1.06% | 352,224 | 10.32M |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | 1.02% | 696,876 | - |
| 372 | SLDB | Solid Biosciences Inc. | 1.09B | 2.12% | 2,083,097 | - |
| 373 | VOR | Vor Biopharma Inc. | 1.09B | -2.38% | 1,460,151 | - |
| 374 | CNMD | CONMED Corporation | 1.06B | 3.78% | 538,123 | 1.37B |
| 375 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | 0.65% | 1,322,415 | 1.03B |
| 376 | CRON | Cronos Group Inc. | 1.05B | -3.50% | 808,821 | 159.54M |
| 377 | AVTX | Avalo Therapeutics, Inc. | 1.05B | 5.94% | 1,520,388 | 59.00K |
| 378 | EVO | Evotec SE | 1.05B | 0.17% | 37,605 | 859.03M |
| 379 | GDRX | GoodRx Holdings, Inc. | 1.04B | 0.98% | 1,260,205 | 787.89M |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 1.04B | 1.39% | 369,671 | 86.93M |
| 381 | SPTX | Seaport Therapeutics, Inc. | 1.04B | -5.83% | 141,856 | - |
| 382 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | - | 2,219,025 | 69.64M |
| 383 | AVR | Anteris Technologies Global Corp. | 1.03B | 3.22% | 2,178,159 | 1.85M |
| 384 | PCRX | Pacira BioSciences, Inc. | 1.01B | 0.79% | 296,380 | 734.86M |
| 385 | PHAR | Pharming Group N.V. | 992.29M | 2.90% | 10,295 | 369.49M |
| 386 | BVS | Bioventus Inc. | 984.04M | 12.40% | 1,415,616 | 576.30M |
| 387 | ABUS | Arbutus Biopharma Corporation | 981.76M | 2.05% | 2,629,108 | 191.45M |
| 388 | KURA | Kura Oncology, Inc. | 980.07M | -0.54% | 1,350,507 | 71.64M |
| 389 | ANNX | Annexon, Inc. | 976.50M | 9.16% | 6,777,438 | - |
| 390 | REPL | Replimune Group, Inc. | 962.85M | -0.95% | 1,401,745 | - |
| 391 | LBRX | LB Pharmaceuticals Inc | 958.37M | -0.03% | 232,707 | - |
| 392 | JANX | Janux Therapeutics, Inc. | 939.77M | -0.84% | 607,454 | 13.73M |
| 393 | DBVT | DBV Technologies S.A. | 937.95M | -1.33% | 159,101 | 5.74M |
| 394 | DSGN | Design Therapeutics, Inc. | 927.49M | -5.05% | 838,521 | - |
| 395 | INMD | InMode Ltd. | 925.04M | -1.35% | 407,416 | 374.64M |
| 396 | GERN | Geron Corporation | 923.79M | 5.88% | 11,306,884 | 196.12M |
| 397 | IVA | Inventiva S.A. | 921.33M | -0.26% | 3,001,037 | 7.94M |
| 398 | ANRO | Alto Neuroscience, Inc. | 920.16M | 5.81% | 677,405 | - |
| 399 | PHAT | Phathom Pharmaceuticals, Inc. | 908.28M | 2.10% | 835,645 | 204.89M |
| 400 | TALK | Talkspace, Inc. | 877.77M | 0.77% | 3,698,922 | 238.37M |
| 401 | TBPH | Theravance Biopharma, Inc. | 876.40M | 0.41% | 595,924 | 109.78M |
| 402 | AMPH | Amphastar Pharmaceuticals, Inc. | 864.66M | -0.15% | 313,781 | 720.53M |
| 403 | HSTM | HealthStream, Inc. | 849.29M | 2.32% | 144,569 | 311.78M |
| 404 | OCS | Oculis Holding AG | 835.17M | -2.05% | 362,537 | 1.40M |
| 405 | TENX | Tenax Therapeutics, Inc. | 830.75M | 5.17% | 1,501,746 | - |
| 406 | CTMX | CytomX Therapeutics, Inc. | 829.45M | -0.26% | 3,200,157 | 35.54M |
| 407 | SPRY | ARS Pharmaceuticals, Inc. | 827.20M | -2.69% | 960,991 | 98.99M |
| 408 | ZVRA | Zevra Therapeutics, Inc. | 825.84M | -0.07% | 1,001,642 | 122.29M |
| 409 | ESPR | Esperion Therapeutics, Inc. | 810.91M | -0.32% | 6,814,760 | 418.24M |
| 410 | ODTX | Odyssey Therapeutics, Inc. | 788.79M | -1.93% | 154,724 | 1.06M |
| 411 | SIBN | SI-BONE, Inc. | 783.65M | 3.27% | 414,004 | 206.22M |
| 412 | AURA | Aura Biosciences, Inc. | 782.02M | -8.40% | 544,528 | - |
| 413 | GMRS | GMR Solutions Inc. | 776.69M | -0.96% | 253,729 | 5.83B |
| 414 | ACRS | Aclaris Therapeutics, Inc. | 766.75M | -1.26% | 1,193,633 | 8.37M |
| 415 | RGNX | REGENXBIO Inc. | 766.68M | 11.67% | 2,958,048 | 87.82M |
| 416 | SSII | SS Innovations International, Inc. | 766.50M | 1.32% | 47,363 | 48.47M |
| 417 | SLBT | SL Science Holding Limited | 762.06M | -21.29% | 330,713 | - |
| 418 | CLYM | Climb Bio, Inc. | 761.56M | 3.10% | 2,075,173 | - |
| 419 | CBLL | CeriBell, Inc. | 750.89M | 1.23% | 360,637 | 95.07M |
| 420 | OMER | Omeros Corporation | 748.36M | 11.42% | 1,745,282 | 9.89M |
| 421 | BBNX | Beta Bionics, Inc. | 745.07M | -0.24% | 694,642 | 110.24M |
| 422 | RIGL | Rigel Pharmaceuticals, Inc. | 744.80M | 3.96% | 378,195 | 299.77M |
| 423 | IMMX | Immix Biopharma, Inc. | 743.93M | 1.12% | 1,320,098 | - |
| 424 | CADL | Candel Therapeutics, Inc. | 734.90M | 2.03% | 1,074,746 | - |
| 425 | CSTL | Castle Biosciences, Inc. | 733.98M | 0.37% | 187,687 | 339.92M |
| 426 | IRWD | Ironwood Pharmaceuticals, Inc. | 723.48M | 1.50% | 2,991,438 | 361.51M |
| 427 | ALLO | Allogene Therapeutics, Inc. | 721.37M | 0.48% | 10,843,977 | 22.00K |
| 428 | PRME | Prime Medicine, Inc. | 720.66M | 3.10% | 4,449,912 | 4.03M |
| 429 | TCMD | Tactile Systems Technology, Inc. | 719.09M | 1.69% | 182,412 | 343.52M |
| 430 | TRAX | First Tracks Biotherapeutics, Inc. | 699.24M | 3.83% | 588,281 | - |
| 431 | CRMD | CorMedix Inc. | 689.59M | 0.46% | 1,180,419 | 400.05M |
| 432 | PHR | Phreesia, Inc. | 686.11M | 1.46% | 842,706 | 495.59M |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 672.90M | 3.58% | 263,856 | - |
| 434 | AGMB | AgomAb Therapeutics NV | 669.67M | 7.49% | 107,116 | - |
| 435 | FDMT | 4D Molecular Therapeutics, Inc. | 664.69M | -2.19% | 873,616 | 88.24M |
| 436 | TECX | Tectonic Therapeutic, Inc. | 664.57M | -7.14% | 244,335 | - |
| 437 | RLMD | Relmada Therapeutics, Inc. | 663.96M | 0.80% | 1,243,396 | - |
| 438 | GYRE | Gyre Therapeutics, Inc. | 663.36M | -1.09% | 132,744 | 117.05M |
| 439 | ACHV | Achieve Life Sciences, Inc. | 662.15M | 0.78% | 1,159,420 | - |
| 440 | DNA | Ginkgo Bioworks Holdings, Inc. | 660.43M | -2.79% | 1,391,485 | 151.40M |
| 441 | CERS | Cerus Corporation | 657.21M | 3.80% | 4,682,133 | 216.56M |
| 442 | DRUG | Bright Minds Biosciences Inc. | 652.75M | -1.41% | 286,938 | - |
| 443 | EIKN | Eikon Therapeutics, Inc. | 651.56M | -4.03% | 516,685 | - |
| 444 | NGNE | Neurogene Inc. | 648.82M | -7.87% | 229,709 | 925.00K |
| 445 | MNPR | Monopar Therapeutics Inc. | 648.58M | -0.99% | 103,857 | - |
| 446 | EVH | Evolent Health, Inc. | 645.64M | 0.53% | 2,614,434 | 1.89B |
| 447 | BWAY | BrainsWay Ltd. | 636.82M | 5.46% | 133,856 | 56.22M |
| 448 | SGP | SpyGlass Pharma, Inc. | 635.90M | -0.68% | 115,222 | - |
| 449 | FTH | Faeth Therapeutics, Inc. | 629.00M | 6.46% | 72,001 | - |
| 450 | NVCT | Nuvectis Pharma, Inc. | 618.85M | 0.31% | 541,570 | - |
| 451 | PROK | ProKidney Corp. | 610.16M | -0.49% | 1,144,612 | 889.00K |
| 452 | FLGT | Fulgent Genetics, Inc. | 607.49M | 2.59% | 147,304 | 320.35M |
| 453 | MDXG | MiMedx Group, Inc. | 606.21M | 3.04% | 890,553 | 389.42M |
| 454 | CTKB | Cytek Biosciences, Inc. | 599.22M | 1.09% | 1,046,162 | 204.17M |
| 455 | ALT | Altimmune, Inc. | 598.98M | -2.53% | 4,335,778 | 36.00K |
| 456 | NPCE | NeuroPace, Inc. | 590.84M | 7.37% | 181,351 | 99.53M |
| 457 | CTNM | Contineum Therapeutics, Inc. | 580.80M | 2.88% | 364,371 | - |
| 458 | ASMB | Assembly Biosciences, Inc. | 572.62M | 4.16% | 179,400 | 71.10M |
| 459 | MYGN | Myriad Genetics, Inc. | 569.52M | 0.67% | 882,409 | 829.00M |
| 460 | CTEV | Claritev Corporation | 565.30M | 1.59% | 74,139 | 978.76M |
| 461 | CBIO | Crescent Biopharma, Inc. | 563.56M | -0.76% | 204,123 | 11.88M |
| 462 | EDIT | Editas Medicine, Inc. | 560.14M | - | 2,772,317 | 38.69M |
| 463 | KYTX | Kyverna Therapeutics, Inc. | 556.88M | 3.04% | 859,677 | - |
| 464 | STTK | Shattuck Labs, Inc. | 555.17M | 2.70% | 1,102,388 | 1.00M |
| 465 | XOMA | XOMA Royalty Corporation | 549.92M | 1.98% | 209,008 | 48.56M |
| 466 | ARVN | Arvinas, Inc. | 545.20M | 0.72% | 616,593 | 89.40M |
| 467 | TOI | The Oncology Institute, Inc. | 543.91M | 3.03% | 1,648,918 | 545.76M |
| 468 | ANGO | AngioDynamics, Inc. | 541.03M | -0.84% | 555,746 | 313.73M |
| 469 | CLPT | ClearPoint Neuro, Inc. | 539.81M | -3.79% | 550,687 | 40.61M |
| 470 | WEAV | Weave Communications, Inc. | 533.09M | 1.82% | 718,952 | 248.72M |
| 471 | AQST | Aquestive Therapeutics, Inc. | 531.91M | 1.44% | 1,447,410 | 50.27M |
| 472 | NNNN | Anbio Biotechnology | 528.45M | -5.20% | 83,845 | 8.65M |
| 473 | KIDS | OrthoPediatrics Corp. | 525.26M | 2.51% | 118,743 | 243.30M |
| 474 | TLRY | Tilray Brands, Inc. | 522.46M | -5.19% | 4,726,739 | 858.28M |
| 475 | PACB | Pacific Biosciences of California, Inc. | 515.60M | -1.19% | 3,583,238 | 160.03M |
| 476 | RZLT | Rezolute, Inc. | 515.54M | 0.51% | 1,629,095 | - |
| 477 | ZURA | Zura Bio Limited | 509.19M | 3.68% | 925,994 | - |
| 478 | NRC | NRC Health | 508.20M | 0.67% | 85,790 | 138.64M |
| 479 | STRO | Sutro Biopharma, Inc. | 507.55M | 0.66% | 358,508 | 99.61M |
| 480 | OCGN | Ocugen, Inc. | 504.40M | -1.32% | 4,942,360 | 4.47M |
| 481 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 482 | VALN | Valneva SE | 500.21M | 3.35% | 20,285 | 180.25M |
| 483 | SLN | Silence Therapeutics plc | 498.79M | 1.64% | 578,868 | 839.00K |
| 484 | FBRX | Forte Biosciences, Inc. | 498.73M | -2.44% | 217,005 | - |
| 485 | CYH | Community Health Systems, Inc. | 498.47M | -5.64% | 1,502,919 | 12.29B |
| 486 | PRTA | Prothena Corporation plc | 497.36M | -1.96% | 403,737 | 57.94M |
| 487 | PRLD | Prelude Therapeutics Incorporated | 494.90M | 1.63% | 241,242 | 16.72M |
| 488 | CABA | Cabaletta Bio, Inc. | 490.79M | -5.64% | 7,494,338 | - |
| 489 | OVID | Ovid Therapeutics Inc. | 487.13M | -2.97% | 1,014,979 | 7.12M |
| 490 | SGMT | Sagimet Biosciences Inc. | 477.96M | 1.71% | 752,072 | - |
| 491 | SRTA | Strata Critical Medical, Inc. | 470.70M | 0.55% | 1,264,016 | 228.58M |
| 492 | OFIX | Orthofix Medical Inc. | 467.68M | 16.40% | 941,934 | 825.37M |
| 493 | DCTH | Delcath Systems, Inc. | 465.35M | 2.12% | 480,822 | 90.44M |
| 494 | VMD | Viemed Healthcare, Inc. | 465.03M | 0.92% | 384,669 | 286.57M |
| 495 | EOLS | Evolus, Inc. | 460.32M | 1.30% | 558,885 | 301.79M |
| 496 | ARTV | Artiva Biotherapeutics, Inc. | 458.67M | -1.77% | 839,015 | 251.00K |
| 497 | CCCC | C4 Therapeutics, Inc. | 457.75M | -3.72% | 1,760,333 | 34.86M |
| 498 | BNTC | Benitec Biopharma Inc. | 453.48M | -0.15% | 131,073 | - |
| 499 | VREX | Varex Imaging Corporation | 452.65M | 1.23% | 364,647 | 857.50M |
| 500 | SOPH | SOPHiA GENETICS SA | 448.00M | -0.19% | 475,680 | 81.18M |